120 related articles for article (PubMed ID: 7584632)
1. Kinetics for the inhibition of acetylcholinesterase from human erythrocyte by cisplatin.
Aljafari AA
Int J Biochem Cell Biol; 1995 Sep; 27(9):965-70. PubMed ID: 7584632
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II).
Kamal MA
Anticancer Res; 1997; 17(6D):4487-91. PubMed ID: 9494556
[TBL] [Abstract][Full Text] [Related]
3. The mode of inhibition of human erythrocyte membrane-bound acetylcholinesterase by cisplatin in vitro.
al-Jafari AA; Kamal MA; Duhaiman AS
J Enzyme Inhib; 1995; 8(4):281-9. PubMed ID: 7542325
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate.
Kamal MA; Nasim FH; al-Jafari AA
Mol Cell Biochem; 1996 Jun; 159(1):47-53. PubMed ID: 8813709
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase.
Kamal MA
Anticancer Res; 1996; 16(6B):3725-30. PubMed ID: 9042248
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin.
Al-Jafari AA; Al-Khwyter F; Kamal MA
Cancer Lett; 1998 Jun; 128(1):79-86. PubMed ID: 9652796
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
8. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7) in vitro.
Kamal MA
Biochem Mol Biol Int; 1997 Sep; 43(1):89-97. PubMed ID: 9315286
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Eckert S; Eyer P; Herkert N; Bumm R; Weber G; Thiermann H; Worek F
Biochem Pharmacol; 2008 Feb; 75(3):698-703. PubMed ID: 17977518
[TBL] [Abstract][Full Text] [Related]
10. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
11. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes.
Perry NS; Houghton PJ; Theobald A; Jenner P; Perry EK
J Pharm Pharmacol; 2000 Jul; 52(7):895-902. PubMed ID: 10933142
[TBL] [Abstract][Full Text] [Related]
12. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
Eckert S; Eyer P; Worek F
Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of membrane-bound and solubilized erythrocyte acetylcholinesterase with carbamates].
Kugusheva LI; Rozengart VI; Sherstobitov OE
Ukr Biokhim Zh (1978); 1990; 62(1):34-9. PubMed ID: 2336723
[TBL] [Abstract][Full Text] [Related]
14. Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor.
Liu W; Tsou CL
Biochim Biophys Acta; 1986 Mar; 870(2):185-90. PubMed ID: 3955054
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase.
Kamal MA; Nasim FH; al-Jafari AA
Biochem Mol Biol Int; 1996 May; 39(2):293-302. PubMed ID: 8799456
[TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
17. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
[TBL] [Abstract][Full Text] [Related]
18. Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.
Lin G; Lai CY; Liao WC
Bioorg Med Chem; 1999 Dec; 7(12):2683-9. PubMed ID: 10658572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
